Fiera Capital Corp Seagen Inc. Transaction History

Fiera Capital Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$108.81 - $179.33 $1.15 Million - $1.9 Million	-10,610 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$119.61 - $157.85 $1.27 Million - $1.67 Million	10,610 New	10,610 $1.53 Million
Q2 2021 Aug 11, 2021	SELL	$135.08 - $161.1 $1.77 Million - $2.11 Million	-13,115 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$137.51 - $190.8 $96,944 - $134,514	705 Added 5.68%	13,115 $1.82 Million
Q4 2020 Feb 09, 2021	BUY	$164.63 - $211.93 $2.04 Million - $2.63 Million	12,410 New	12,410 $2.17 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Fiera Capital Corp, based on Form 13F filings with the SEC.

Stay updated on Fiera Capital Corp with notifications on news.